Alzheimer's soluble amyloid beta is a normal component of human urine

FEBS Letters
J GhisoB Frangione

Abstract

Soluble A beta (Sa beta) is normally present at a low concentration in human plasma and cerebrospinal fluid. Although the factors involved in the regulation of Sa beta plasma levels are still unknown, we have explored its excretion in the urine as one of the possible homeostatic mechanisms. The presence of Sa beta in the urine was investigated via immunoprecipitation experiments with anti-A beta antibodies followed by detection and identification by immunoblot, MALDI mass spectrometry and sequence analysis. Soluble A beta (4.3 kDa) immunoreactivity was present in the urine of normal donors, Down's syndrome individuals as well as in patients with renal disorders exhibiting glomerular or mixed proteinuria. Edman degradation of the immunoprecipitated material yielded the intact A beta N-terminus and mass spectra analysis indicated the existence of a major component at mlz 4327, corresponding to the molecular mass of A beta1-40. Semiquantitative data obtained from the immunoprecipitation experiments indicate that under normal conditions the daily excretion of intact Sa beta in the urine represents less than 1% of the circulating pool.

References

Mar 31, 1995·The Journal of Biological Chemistry·E MatsubaraJ Ghiso
Mar 1, 1994·Neurobiology of Aging·T WisniewskiB Frangione
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·J NäslundP Greengard
May 16, 1994·Biochemical and Biophysical Research Communications·M TabatonP Gambetti
Nov 1, 1993·Journal of Neurochemistry·C Vigo-PelfreyD B Schenk
Dec 30, 1993·Biochemical and Biophysical Research Communications·B V ZlokovicB Frangione
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J BusciglioB A Yankner
Jun 1, 1996·The Biochemical Journal·E MatsubaraJ Ghiso

❮ Previous
Next ❯

Citations

Feb 19, 2000·Biochemical and Biophysical Research Communications·Y M KuoA E Roher
Nov 28, 2002·Advanced Drug Delivery Reviews·Jorge Ghiso, Blas Frangione
Jun 28, 2003·Biochimica Et Biophysica Acta·Rajadas JayakumarJoseph M Rifkind
May 18, 2001·The New England Journal of Medicine·S B Prusiner
Sep 10, 2002·Alzheimer Disease and Associated Disorders·Zoe ArvanitakisNeill R Graff-Radford
Mar 9, 2013·Alzheimer's Research & Therapy·Jon B ToledoJohn Q Trojanowski
Jul 15, 2015·Expert Review of Proteomics·Sara GalozziKatalin Barkovits
Dec 29, 2000·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·H VandersticheleE Vanmechelen
Aug 1, 1998·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·D B Teplow
Aug 24, 2004·The Journal of Biological Chemistry·Jorge GhisoBlas Frangione
Dec 14, 2002·Annals of the New York Academy of Sciences·E MatsubaraJ Ghiso
Sep 30, 2017·Nature Reviews. Neurology·Jun WangYan-Jiang Wang
Dec 20, 2015·Journal of Alzheimer's Disease : JAD·Susanne TholenTimo Grimmer
Jan 3, 2009·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Alex E RoherMarwan N Sabbagh
Aug 11, 2000·Microscopy Research and Technique·M CaleroJ Ghiso
May 28, 2020·Frontiers in Aging Neuroscience·Ines Moreno-GonzalezRaquel Sanchez-Varo
Nov 28, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Dearbhla M Kelly
Jul 31, 2002·Brain Pathology·Tamas ReveszBlas Frangione
Feb 24, 2001·Annals of the New York Academy of Sciences·J GhisoB Frangione
Jun 25, 2020·Current Cardiology Reports·Gianlorenzo DanieleFederica Del Monte
Oct 10, 2003·Journal of Neuropathology and Experimental Neurology·Tamas ReveszJanice L Holton
Apr 27, 2021·Journal of Alzheimer's Disease : JAD·Vince SzegeczkiTamás Juhász
Jul 19, 2000·Biochimica Et Biophysica Acta·A E RoherM R Emmerling
Feb 18, 2020·Neuro-degenerative Diseases·Jan Klohs

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis
J GhisoB Frangione
Journal of Internal Medicine
C NorstedtB Winblad
© 2021 Meta ULC. All rights reserved